Bedel Financial Consulting’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $901K | Buy |
7,015
+86
| +1% | +$10.1K | 0.08% | 121 |
|
|
2026
Q1 | $833K | Buy |
6,929
+4
| +0.1% | +$462 | 0.09% | 119 |
|
|
2025
Q4 | $729K | Buy |
6,925
+4
| +0.1% | +$375 | 0.08% | 129 |
|
|
2025
Q3 | $581K | Buy |
6,921
+479
| +7% | +$39.5K | 0.07% | 142 |
|
|
2025
Q2 | $510K | Sell |
6,442
-95
| -1% | -$7.55K | 0.07% | 156 |
|
|
2025
Q1 | $517K | Buy |
6,537
+64
| +1% | +$5.97K | 0.07% | 143 |
|
|
2024
Q4 | $580K | Buy |
6,473
+7
| +0.1% | +$722 | 0.08% | 135 |
|
|
2024
Q3 | $734K | Sell |
6,466
-535
| -8% | -$63.6K | 0.1% | 105 |
|
|
2024
Q2 | $867K | Buy |
7,001
+741
| +12% | +$95.4K | 0.13% | 87 |
|
|
2024
Q1 | $826K | Sell |
6,260
-80
| -1% | -$9.86K | 0.13% | 88 |
|
|
2023
Q4 | $691K | Buy |
6,340
+181
| +3% | +$18.8K | 0.13% | 97 |
|
|
2023
Q3 | $634K | Sell |
6,159
-16
| -0.3% | -$1.73K | 0.13% | 97 |
|
|
2023
Q2 | $713K | Buy |
6,175
+54
| +0.9% | +$6.13K | 0.15% | 84 |
|
|
2023
Q1 | $651K | Sell |
6,121
-269
| -4% | -$29K | 0.16% | 89 |
|
|
2022
Q4 | $709K | Sell |
6,390
-100
| -2% | -$10.2K | 0.18% | 80 |
|
|
2022
Q3 | $649K | Sell |
6,490
-270
| -4% | -$24.1K | 0.17% | 81 |
|
|
2022
Q2 | $616K | Buy |
6,760
+795
| +13% | +$70.5K | 0.18% | 76 |
|
|
2022
Q1 | $489K | Hold |
5,965
| – | – | 0.15% | 99 |
|
|
2021
Q4 | $457K | Hold |
5,965
| – | – | 0.14% | 107 |
|
|
2021
Q3 | $448K | Hold |
5,965
| – | – | 0.15% | 100 |
|
|
2021
Q2 | $464K | Sell |
5,965
-77
| -1% | -$5.73K | 0.16% | 98 |
|
|
2021
Q1 | $444K | Buy |
6,042
+3,578
| +145% | +$264K | 0.17% | 98 |
|
|
2020
Q4 | $192K | Hold |
2,464
| – | – | 0.09% | 155 |
|
|
2020
Q3 | $195K | Sell |
2,464
-69
| -3% | -$5.41K | 0.1% | 144 |
|
|
2020
Q2 | $187K | Hold |
2,533
| – | – | 0.1% | 138 |
|
|
2020
Q1 | $186K | Buy |
2,533
+60
| +2% | +$4.72K | 0.12% | 124 |
|
|
2019
Q4 | $215K | Buy |
2,473
+42
| +2% | +$3.45K | 0.12% | 135 |
|
|
2019
Q3 | $195K | Hold |
2,431
| – | – | 0.12% | 141 |
|
|
2019
Q2 | $194K | Buy |
2,431
+1
| +0% | +$77 | 0.12% | 139 |
|
|
2019
Q1 | $193K | Hold |
2,430
| – | – | 0.12% | 134 |
|
|
2018
Q4 | $177K | Sell |
2,430
-210
| -8% | -$14.8K | 0.13% | 130 |
|
|
2018
Q3 | $179K | Buy |
2,640
+211
| +9% | +$13.4K | 0.12% | 147 |
|
|
2018
Q2 | $141K | Buy |
2,429
+78
| +3% | +$4.4K | 0.1% | 162 |
|
|
2018
Q1 | $122K | Buy |
+2,351
| New | +$127K | 0.09% | 178 |
|
Other funds holding MRK
ECSS
Bedel Financial Consulting's MRK Position: Q2 2026 in Review
Bedel Financial Consulting increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $10.1K and bringing the position to 7,015 shares worth $901K. The position accounts for 0.08% of the portfolio, ranked #121.
Bedel Financial Consulting first reported a position in MRK in Q1 2018 and has held it in 34 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Bedel Financial Consulting held 7,015 shares of Merck worth $901K as of Q2 2026.
- Bedel Financial Consulting bought 86 Merck shares in Q2 2026, an estimated $10.1K.
- Merck made up 0.08% of Bedel Financial Consulting's portfolio in Q2 2026, its #121 holding.
- Bedel Financial Consulting first reported a position in Merck in Q1 2018 and has held it in 34 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.